Alector Company
Biopharmaceutical companyВідповідно до джерел: 2Alector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration Therapeutics for is a biopharmaceutical company that provides therapies for the treatment of neurodegenerative diseases. It offers latozinemab (also referred to as AL001), AL002, and AL101 product Company Profile - …
Investors
Estimated Revenue:
US$45m
Industry:
Early Drug Development
Headquarters:
131 Oyster Point Blvd, Suite 600, South San Francisco, CA 94080
Number Of Exists:
101-250
Founded Date:
2013.0
Employee Number:
262